+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Drug Discovery Technologies Market Research Report by Technology, End-user, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4896655
  • Report
  • October 2021
  • Region: Global
  • 197 pages
  • 360iResearch™
UP TO OFF
until Jan 01st 2022
Global Drug Discovery Technologies Market is Projected to Reach USD 91.33 Billion by 2026, Registering a CAGR of 10.54%

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Affymetrix Inc.
  • Agilent Technologies, Inc
  • Arqule Inc.
  • AstraZeneca Plc
  • Bayer Healthcare AG
  • MORE
The Global Drug Discovery Technologies Market size was estimated at USD 50.04 billion in 2020, is expected to reach USD 55.15 billion in 2021, and projected to grow at a CAGR of 10.54% reaching USD 91.33 billion by 2026.



Market Statistics


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage


This research report categorizes the Drug Discovery Technologies to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Technology, the market was studied across Bioanalytical Instruments, Biochips, Bioinformatics, Combinatorial Chemistry, Genomics, High Throughput Screening, Nanotechnology, Pharmacogenomics, and RNAI.
  • Based on End-user, the market was studied across Biopharmaceutical Companies, Biotech Companies, Pharmaceutical Companies, and Research Institutes.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The analyst's ongoing research amplifies their research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Drug Discovery Technologies Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Drug Discovery Technologies Market, including Abbott Laboratories, Inc., Affymetrix Inc., Agilent Technologies, Inc, Albany Molecular Research Inc., Arqule Inc., AstraZeneca Plc, Bayer Healthcare AG, GE Healthcare Ltd., Luminex Corporation, and Novartis AG.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Drug Discovery Technologies Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Discovery Technologies Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Discovery Technologies Market?
4. What is the competitive strategic window for opportunities in the Global Drug Discovery Technologies Market?
5. What are the technology trends and regulatory frameworks in the Global Drug Discovery Technologies Market?
6. What is the market share of the leading vendors in the Global Drug Discovery Technologies Market?
7. What modes and strategic moves are considered suitable for entering the Global Drug Discovery Technologies Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Affymetrix Inc.
  • Agilent Technologies, Inc
  • Arqule Inc.
  • AstraZeneca Plc
  • Bayer Healthcare AG
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increasing incidences of diseases
5.2.2. Increased demand for drug and biologics due to benefits, such as highly effective and potent action, and fewer side effects
5.2.3. Increasing research and development expenditure and investment for development of novel drug molecules
5.3. Restraints
5.3.1. High initial setup cost for drug discovery and development
5.3.2. Need of long duration of drug discovery process
5.4. Opportunities
5.4.1. Patent expiries of several drugs
5.4.2. Advances in the fields of biotechnology, molecular biology, nanotechnology, and genomics
5.5. Challenges
5.5.1. Presence of stringent regulatory environment

6. Drug Discovery Technologies Market, by Technology
6.1. Introduction
6.2. Bioanalytical Instruments
6.3. Biochips
6.4. Bioinformatics
6.5. Combinatorial Chemistry
6.6. Genomics
6.7. High Throughput Screening
6.8. Nanotechnology
6.9. Pharmacogenomics
6.10. RNAI

7. Drug Discovery Technologies Market, by End-user
7.1. Introduction
7.2. Biopharmaceutical Companies
7.3. Biotech Companies
7.4. Pharmaceutical Companies
7.5. Research Institutes

8. Americas Drug Discovery Technologies Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Drug Discovery Technologies Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. Europe, Middle East & Africa Drug Discovery Technologies Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, by Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbott Laboratories, Inc.
12.2. Affymetrix Inc.
12.3. Agilent Technologies, Inc.
12.4. Albany Molecular Research Inc.
12.5. Arqule Inc.
12.6. AstraZeneca Plc
12.7. Bayer Healthcare AG
12.8. GE Healthcare Ltd.
12.9. Luminex Corporation
12.10. Novartis AG

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
Figure 1. Global Drug Discovery Technologies Market Size, 2020 vs 2026 (USD Billion)
Figure 2. Global Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 3. Global Drug Discovery Technologies Market: Market Dynamics
Figure 4. Global Drug Discovery Technologies Market Size, by Technology, 2020 vs 2026 (%)
Figure 5. Global Drug Discovery Technologies Market Size, by Technology, 2020 vs 2026 (USD Billion)
Figure 6. Competitive Strategic Window for Global Drug Discovery Technologies Market Size, by Technology, 2026
Figure 7. Global Drug Discovery Technologies Market Size, by Bioanalytical Instruments, 2018-2026 (USD Billion)
Figure 8. Global Drug Discovery Technologies Market Size, by Bioanalytical Instruments, by Region, 2020 vs 2026 (USD Billion)
Figure 9. Global Drug Discovery Technologies Market Size, by Biochips, 2018-2026 (USD Billion)
Figure 10. Global Drug Discovery Technologies Market Size, by Biochips, by Region, 2020 vs 2026 (USD Billion)
Figure 11. Global Drug Discovery Technologies Market Size, by Bioinformatics, 2018-2026 (USD Billion)
Figure 12. Global Drug Discovery Technologies Market Size, by Bioinformatics, by Region, 2020 vs 2026 (USD Billion)
Figure 13. Global Drug Discovery Technologies Market Size, by Combinatorial Chemistry, 2018-2026 (USD Billion)
Figure 14. Global Drug Discovery Technologies Market Size, by Combinatorial Chemistry, by Region, 2020 vs 2026 (USD Billion)
Figure 15. Global Drug Discovery Technologies Market Size, by Genomics, 2018-2026 (USD Billion)
Figure 16. Global Drug Discovery Technologies Market Size, by Genomics, by Region, 2020 vs 2026 (USD Billion)
Figure 17. Global Drug Discovery Technologies Market Size, by High Throughput Screening, 2018-2026 (USD Billion)
Figure 18. Global Drug Discovery Technologies Market Size, by High Throughput Screening, by Region, 2020 vs 2026 (USD Billion)
Figure 19. Global Drug Discovery Technologies Market Size, by Nanotechnology, 2018-2026 (USD Billion)
Figure 20. Global Drug Discovery Technologies Market Size, by Nanotechnology, by Region, 2020 vs 2026 (USD Billion)
Figure 21. Global Drug Discovery Technologies Market Size, by Pharmacogenomics, 2018-2026 (USD Billion)
Figure 22. Global Drug Discovery Technologies Market Size, by Pharmacogenomics, by Region, 2020 vs 2026 (USD Billion)
Figure 23. Global Drug Discovery Technologies Market Size, by Rnai, 2018-2026 (USD Billion)
Figure 24. Global Drug Discovery Technologies Market Size, by Rnai, by Region, 2020 vs 2026 (USD Billion)
Figure 25. Global Drug Discovery Technologies Market Size, by End-user, 2020 vs 2026 (%)
Figure 26. Global Drug Discovery Technologies Market Size, by End-user, 2020 vs 2026 (USD Billion)
Figure 27. Competitive Strategic Window for Global Drug Discovery Technologies Market Size, by End-user, 2026
Figure 28. Global Drug Discovery Technologies Market Size, by Biopharmaceutical Companies, 2018-2026 (USD Billion)
Figure 29. Global Drug Discovery Technologies Market Size, by Biopharmaceutical Companies, by Region, 2020 vs 2026 (USD Billion)
Figure 30. Global Drug Discovery Technologies Market Size, by Biotech Companies, 2018-2026 (USD Billion)
Figure 31. Global Drug Discovery Technologies Market Size, by Biotech Companies, by Region, 2020 vs 2026 (USD Billion)
Figure 32. Global Drug Discovery Technologies Market Size, by Pharmaceutical Companies, 2018-2026 (USD Billion)
Figure 33. Global Drug Discovery Technologies Market Size, by Pharmaceutical Companies, by Region, 2020 vs 2026 (USD Billion)
Figure 34. Global Drug Discovery Technologies Market Size, by Research Institutes, 2018-2026 (USD Billion)
Figure 35. Global Drug Discovery Technologies Market Size, by Research Institutes, by Region, 2020 vs 2026 (USD Billion)
Figure 36. Americas Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 37. Argentina Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 38. Brazil Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 39. Canada Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 40. Mexico Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 41. United States Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 42. Asia-Pacific Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 43. Australia Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 44. China Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 45. India Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 46. Indonesia Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 47. Japan Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 48. Malaysia Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 49. Philippines Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 50. Singapore Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 51. South Korea Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 52. Taiwan Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 53. Thailand Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 54. Europe, Middle East & Africa Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 55. France Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 56. Germany Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 57. Italy Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 58. Netherlands Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 59. Qatar Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 60. Russia Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 61. Saudi Arabia Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 62. South Africa Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 63. Spain Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 64. United Arab Emirates Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 65. United Kingdom Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Figure 66. Global Drug Discovery Technologies Market: FPNV Positioning Matrix
Figure 67. Global Drug Discovery Technologies Market: Share, by Key Player, 2020
Figure 68. Competitive Scenario Analysis in Global Drug Discovery Technologies Market, by Type

List of Tables
Table 1. Global Drug Discovery Technologies Market: Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016–2020
Table 3. Global Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 4. Global Drug Discovery Technologies Market Size, by Technology, 2018-2026 (USD Billion)
Table 5. Global Drug Discovery Technologies Market Size, by Bioanalytical Instruments, by Region, 2018-2026 (USD Billion)
Table 6. Global Drug Discovery Technologies Market Size, by Biochips, by Region, 2018-2026 (USD Billion)
Table 7. Global Drug Discovery Technologies Market Size, by Bioinformatics, by Region, 2018-2026 (USD Billion)
Table 8. Global Drug Discovery Technologies Market Size, by Combinatorial Chemistry, by Region, 2018-2026 (USD Billion)
Table 9. Global Drug Discovery Technologies Market Size, by Genomics, by Region, 2018-2026 (USD Billion)
Table 10. Global Drug Discovery Technologies Market Size, by High Throughput Screening, by Region, 2018-2026 (USD Billion)
Table 11. Global Drug Discovery Technologies Market Size, by Nanotechnology, by Region, 2018-2026 (USD Billion)
Table 12. Global Drug Discovery Technologies Market Size, by Pharmacogenomics, by Region, 2018-2026 (USD Billion)
Table 13. Global Drug Discovery Technologies Market Size, by Rnai, by Region, 2018-2026 (USD Billion)
Table 14. Global Drug Discovery Technologies Market Size, by End-user, 2018-2026 (USD Billion)
Table 15. Global Drug Discovery Technologies Market Size, by Biopharmaceutical Companies, by Region, 2018-2026 (USD Billion)
Table 16. Global Drug Discovery Technologies Market Size, by Biotech Companies, by Region, 2018-2026 (USD Billion)
Table 17. Global Drug Discovery Technologies Market Size, by Pharmaceutical Companies, by Region, 2018-2026 (USD Billion)
Table 18. Global Drug Discovery Technologies Market Size, by Research Institutes, by Region, 2018-2026 (USD Billion)
Table 19. Americas Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 20. Argentina Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 21. Brazil Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 22. Canada Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 23. Mexico Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 24. United States Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 25. Asia-Pacific Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 26. Australia Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 27. China Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 28. India Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 29. Indonesia Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 30. Japan Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 31. Malaysia Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 32. Philippines Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 33. Singapore Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 34. South Korea Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 35. Taiwan Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 36. Thailand Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 37. Europe, Middle East & Africa Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 38. France Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 39. Germany Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 40. Italy Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 41. Netherlands Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 42. Qatar Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 43. Russia Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 44. Saudi Arabia Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 45. South Africa Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 46. Spain Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 47. United Arab Emirates Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 48. United Kingdom Drug Discovery Technologies Market Size, 2018-2026 (USD Billion)
Table 49. Global Drug Discovery Technologies Market: Scores
Table 50. Global Drug Discovery Technologies Market: Business Strategy
Table 51. Global Drug Discovery Technologies Market: Product Satisfaction
Table 52. Global Drug Discovery Technologies Market: Ranking
Table 53. Global Drug Discovery Technologies Market: Share, by Key Player, 2020
Table 54. Global Drug Discovery Technologies Market: Merger & Acquisition
Table 55. Global Drug Discovery Technologies Market: Agreement, Collaboration & Partnership
Table 56. Global Drug Discovery Technologies Market: New Product Launch & Enhancement
Table 57. Global Drug Discovery Technologies Market: Investment & Funding
Table 58. Global Drug Discovery Technologies Market: Award, Recognition & Expansion
Table 59. Global Drug Discovery Technologies Market: License & Pricing
Note: Product cover images may vary from those shown
  • Abbott Laboratories, Inc.
  • Affymetrix Inc.
  • Agilent Technologies, Inc
  • Albany Molecular Research Inc.
  • Arqule Inc.
  • AstraZeneca Plc
  • Bayer Healthcare AG
  • GE Healthcare Ltd.
  • Luminex Corporation
  • Novartis AG
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll